Johnson & Johnson inks $297M opioid deal with Texas as national deal faces holdouts

Johnson & Johnson and the United States' three top drug distributors already agreed to a national opioid settlement worth $26 billion. But because that deal has yet to be finalized, the pharma giant is moving forward with a separate deal with Texas.